Blog - Page 1071 of 5757

WednesdayApr 06, 2022 9:15 am

Paris NFT and Blockchain Week Summit to Witness A New Era of Digital Assets Finance

Entrepreneurs, businesses, and enthusiasts of the modern finance, fintech, and digital assets niche are invited to attend the Paris Blockchain Week Summit being held at none other than the iconic Palais Brongniart. As an extension of the event, the PBWS will include the Paris NFT day on 12 April, to educate and spread awareness about NFT trading. Paris NFT Day Join in for an interactive session on NFTs and Web 3 ecosystem at the Paris NFT Day on 12 April. The conferences will offer a clear understanding of the projects and businesses that are underway in this niche and the key…

WednesdayApr 06, 2022 9:15 am

The Plant Medicine Week Being Held At A Heritage Venue In Malta Hosting Industry Leading Professionals

The Microdose Plant Medicine Week will be held on April 5-8th 2022, at the Mediterranean Conference Centre, one of the finest heritage buildings of Valletta, Malta. The Centre is a landmark venue having membership of the prestigious Historic Conference Centres of Europe (“HCCE”). Investors, entrepreneurs, psychedelic and cannabis researchers, policymakers, and professionals from the health, legislation, and education fields are invited to attend the event. The agenda of the event focuses on the expansion of cannabis and psychedelic medicine usage and trade on the island and reviewing the existing laws and schemes to encourage cannabis investment opportunities in Malta. Knowledge…

WednesdayApr 06, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Lexaria is a global innovator that has developed the patented DehydraTECH(TM) technology that improves bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“APIs”) The company strategically partners with third-party organizations seeking to explore formulation opportunities with their specific APIs Lexaria is evaluating the effectiveness of various DehydraTECH-processed APIs, including CBD, nicotine, sildenafil, and more According to company CEO Chris Bunka, the management team is positioning the company to ensure that it has multiple paths to success In pursuit of multiple paths to success, Lexaria Bioscience (NASDAQ: LEXX), developer of the patented DehydraTECH(TM) drug delivery platform, strategically partners…

WednesdayApr 06, 2022 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Poised to Benefit as Non-Automotive Sector Becomes Increasingly Important for LiDAR Producers

LiDARs have been one of key enablers for autonomous vehicle sector, but this unique technology offers use cases beyond automotive industry Consumer Electronics Show, one of the world’s most influential tech events, demonstrates that LiDAR is growing within non-automotive landscape, including smart city/infrastructure and security Cepton set to benefit as the Company has already established its presence in non-automotive, delivering LiDAR systems for smart cities, spaces, and industrial applications around the globe Cepton (NASDAQ: CPTN), a Silicon Valley leader in innovative, high-performance LiDAR solutions, appears well-positioned to benefit as the non-automotive applications of the LiDAR technology grow. LiDAR technology seems…

WednesdayApr 06, 2022 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potential InMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its CBC and CBT products The company recently reported its first revenues from CBC sales in the wake of its acquisition of rare cannabinoids manufacturer BayMedica late last year The company is also working to develop synthetic CBN cannabinoids as potential medical treatments for select conditions,…

TuesdayApr 05, 2022 3:47 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q4 and Fiscal Year 2021 Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced financial results for the fourth quarter and fiscal year ended Dec. 31, 2021. The company also provided a business update and offered guidance on its strategic changes and growth acceleration planned for FY 2022. “The PCT and BaroFold technologies have provided important early opportunities for commercial traction, as PBI forged scientific understanding and acceptance for its high-pressure platforms,” Jeffrey N. Peterson, chairman of the PBI board, said in the press release. “Building…

TuesdayApr 05, 2022 2:23 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Shares Insight into ‘Secret Lab’ Space, Purpose

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., are providing a rare look at Applied Magix’s “secret lab.” Applied Magix develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar smart home and connected car markets, and the lab is a space where the company investigates and explores technologies and possible products. According to the company, while not everything explored in the lab will be realized or released, parts of the research improve and enhance current products and services or may be woven into smart homes and connected cars. “The Secret Lab is very much…

TuesdayApr 05, 2022 2:10 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Receives Key Approval for Pivotal Study of Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has received key approval for a planned study. The approval came from Swissmedic, the Swiss agency for therapeutic products. CNSP can now move forward with its potentially pivotal study of its novel anthracycline, Berubicin, for the treatment of recurrent glioblastoma multiforme (“GBM”); the company has already received approval from swissethics, the umbrella organization of the cantonal Ethics Committees in Switzerland, for the study. According to the announcement, execution of global patient enrollment is moving forward."With the necessary…

TuesdayApr 05, 2022 2:02 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX) Founder Featured in Bell2Bell Podcast

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies., is spotlighted in the latest episode from the Bell2Bell podcast. ACTX founder and chair Doug Heldoorn chatted with host Stuart Smith, providing insight into the company, the agricultural advantages of Grow Pods and the potential of the company. Heldoorn also discussed Advanced Container Technologies’ operational goals for the remainder of 2022 and beyond. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. “As excited as everybody is about the cannabis industry,…

TuesdayApr 05, 2022 1:56 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Appoints Hull Xu as Chief Financial Officer

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced the appointment of Hull Xu, the company’s VP of finance and strategy, to the position of chief financial officer. Effective immediately, Xu succeeds Dr. Winston Fu, Ph.D., who will remain with the company as an advisor on strategic projects. Dr. Fu will also remain on the board of directors and become vice chairman. “Hull has demonstrated tremendous leadership and experience in finance and strategic matters since he joined Cepton,” said Dr. Jun Pei, Cepton’s co-founder, chairman and CEO. “We look forward to Hull’s continued…

Site Search

Company Search

Paris NFT and Blockchain Week Summit to Witness A New Era of Digital Assets Finance

The Plant Medicine Week Being Held At A Heritage Venue In Malta Hosting Industry Leading Professionals

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Cepton, Inc. (NASDAQ: CPTN) Poised to Benefit as Non-Automotive Sector Becomes Increasingly Important for LiDAR Producers

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q4 and Fiscal Year 2021 Results, Provides Business Update

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Shares Insight into ‘Secret Lab’ Space, Purpose

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Receives Key Approval for Pivotal Study of Berubicin

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX) Founder Featured in Bell2Bell Podcast

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Appoints Hull Xu as Chief Financial Officer

Market Basics

Newsletter Publishers

Public Companies